Clinical Research Directory

Inclusion Criteria: * Age between 18 and 65 years; * Male pattern baldness identified according the Norwood Hamilton scale: stage IIIv vertex, stage IV, or stage V; * Terminal hair density equal to or less than 220 hairs/cm2 measured with the Trichoscale Al; * Subjects who are willing and able to comply with all requirements of the study for the intended period; * Subjects who give their consent to the study after thoroughly clarification and who personally signed and dated the informed consent document has been informed of all pertinent aspects of the trial; Exclusion Criteria: * Current or 6 months dated back use of: * Minoxidil, finasteride, or any 5 alpha-reductase inhibitor; * Medications that can potentiate Hypertrichosis, such as: cyclosporine, phenytoin, psolarenes, oral glucocorticoids (except inhalers), lithium, phenothiazinics * Medications with anti-androgenic properties, such as: cyproterone, spironolactone, ketoconazole, flutamide, bicalutamide. * Any anabolic steroid ; * Current or 8 weeks dated back use of herbal products such as saw palmetto; * Isotretinoin for at least 12 months; * Current or 2 weeks dated back use of dietary or vitamin supplements; * Subjects who had a dignosis of malignant disease in the alopecia area in the period of 05 years;